Search clinical trials for: bimatoprost Formulation C
Total 5005 results
-
AllerganCompletedAlopecia | Alopecia, Androgenetic | BaldnessUnited States
-
AllerganCompletedAlopecia | BaldnessUnited States, Germany
-
AllerganCompletedAlopecia | Alopecia, Androgenetic | BaldnessUnited States, Germany
-
AllerganCompletedAndrogenetic AlopeciaUnited States
-
AllerganCompletedIdiopathic Eyelash HypotrichosisRussian Federation, Sweden, United States, United Kingdom
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | Primary Open-Angle GlaucomaUnited States
-
Singapore National Eye CentreAllerganUnknownGlaucoma, Angle-ClosureSingapore
-
Boehringer IngelheimCompleted
-
GlaxoSmithKlineCompletedMultiple SclerosisPoland, Germany, Czechia
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
Lyndra Inc.CompletedHealthy | Gastric RetentionAustralia
-
Vertex Pharmaceuticals IncorporatedCompletedChronic Hepatitis CUnited States
-
ViiV HealthcareRecruiting
-
PfizerTerminatedRespiratory Tract InfectionUnited States, Australia
-
PfizerRecruitingHealthy Subjects | Healthy ParticipantsUnited States
-
PfizerCompleted
-
PfizerActive, not recruitingClostridoides Difficile Associated DiseaseUnited States
-
Bristol-Myers SquibbCompletedHeart FailureUnited States
-
ViiV HealthcareGlaxoSmithKlineNot yet recruiting
-
GlaxoSmithKlineCompletedSleep Initiation and Maintenance DisordersItaly
-
AllerganCompletedHealthy VolunteersUnited States
-
AllerganCompletedErythema | RosaceaUnited States
-
Janssen Sciences Ireland UCCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimActive, not recruiting
-
AstraZenecaParexelCompletedCoronary Artery Disease (CAD)United Kingdom
-
Janssen Research & Development, LLCCompleted
-
AllerganTerminatedGlaucomaUnited Kingdom, Taiwan, Korea, Republic of, United States, Italy, Philippines, France
-
GlaxoSmithKlineCompletedCrohn's DiseaseUnited States
-
AllerganCompletedAlopecia | Alopecia, Androgenetic | BaldnessUnited States
-
AllerganCompletedOcular Hypertension | Open-Angle GlaucomaUnited States, Israel, Canada, Singapore, Philippines, Spain, Australia, Belgium, Brazil, Germany
-
Inventprise Inc.PATH; Canadian Center for Vaccinology; Vaccine Evaluation Center, CanadaActive, not recruitingPneumococcal VaccinesCanada
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleUnited States
-
Kenneth BeerAllerganCompleted
-
Hillel Yaffe Medical CenterUnknown
-
AbbVieActive, not recruitingOcular Hypertension | Open-Angle GlaucomaUnited States, Argentina, Australia, Bulgaria, Czechia, Denmark, Germany, Hungary, Ireland, Italy, New Zealand, Poland, Russian Federation, South Africa, Sweden, United Kingdom
-
AllerganCompletedEyelash HypotrichosisJapan
-
AllerganCompletedOcular Hypertension | GlaucomaSpain, Czech Republic, Germany, Russian Federation, Hungary, Australia, Israel, United Kingdom, United States
-
AllerganCompleted
-
AbbVieCompletedOcular Hypertension | Open-Angle GlaucomaUnited States
-
Sanofi Pasteur, a Sanofi CompanyCompletedTetanus Immunisation (Healthy Volunteers) | Diphtheria Immunisation (Healthy Volunteers) | Pertussis Immunisation (Healthy Volunteers)Canada
-
AllerganCompletedGlaucoma | Open-Angle Ocular HypertensionSpain, United States, Singapore, Australia, Denmark, France, Poland, Russian Federation, Thailand
-
Boehringer IngelheimCompleted
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
Laboratoires TheaCompleted
-
Johns Hopkins UniversityRecruiting
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleNetherlands
-
AllerganCompletedA Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)Ocular Hypertension | Glaucoma, Open-AngleGermany
-
AllerganCompletedOcular HypertensionUnited States